Entecavir and Hepatitis B Background on Hepatitis B Hepatitis B virus (HBV) is highly endemic in South Africa and across sub-Saharan Africa, where around 8% of people are chronically infected, and rates of HBV-related li

First Page		Document Content
Date: 2014-10-16 05:12:36 Purines Viral hepatitis Hepatitis B Lamivudine Hepatitis C Hepatocellular carcinoma Viral disease HBsAg Evergreening Medicine Bristol-Myers Squibb Entecavir		Entecavir and Hepatitis B Background on Hepatitis B Hepatitis B virus (HBV) is highly endemic in South Africa and across sub-Saharan Africa, where around 8% of people are chronically infected, and rates of HBV-related li Add to Reading List Source URL: www.fixthepatentlaws.org Download Document from Source Website File Size: 302,27 KB Share Document on Facebook

	Working Paper Series NoFIRST-MOVER ADVANTAGES BEFORE AND AFTER TRIPS Evidence from the Indian Pharmaceutical Industry Ajay Bhaskarabhatla DocID: 1p6Uw - View Document
	PDF Document DocID: 1fWv5 - View Document
	Submission to the Department of Foreign Affairs and Trade: The Trans Pacific Partnership Agreement, Intellectual Property and Medicines 1 October, 2013 DocID: 18yKo - View Document
	Entecavir and Hepatitis B Background on Hepatitis B Hepatitis B virus (HBV) is highly endemic in South Africa and across sub-Saharan Africa, where around 8% of people are chronically infected, and rates of HBV-related li DocID: 18mXH - View Document
	Australia and New Zealand Health Policy BioMed Central Open Access DocID: 187up - View Document